Carlos Bonilla
Corporate Officer/Principal bei Carlos J. Bonilla & Associates PL
Vermögen: 1 Mio $ am 31.05.2024
Aktive Positionen von Carlos Bonilla
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Carlos J. Bonilla & Associates PL | Corporate Officer/Principal | 12.05.2011 | - |
Karriereverlauf von Carlos Bonilla
Ehemalige bekannte Positionen von Carlos Bonilla
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
XenaCare Holdings, Inc.
 XenaCare Holdings, Inc. Pharmaceuticals: OtherHealth Technology XenaCare Holdings, Inc. engages in the formulation, marketing and distribution of nutrition supplement products. It offers Cobroxin for pain medication, XenaCor and XenaTri for cardiovascular health, XenaZyme Plus supports digestion and SunPill for skin protection against ultraviolet rays. The company was founded by Alan P. Xenakis in June 2005 and is headquartered in Tampa, FL. | Direktor/Vorstandsmitglied | 25.03.2011 | - |
| Independent Dir/Board Member | 24.03.2011 | - |
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
XenaCare Holdings, Inc.
XenaCare Holdings, Inc. Pharmaceuticals: OtherHealth Technology XenaCare Holdings, Inc. engages in the formulation, marketing and distribution of nutrition supplement products. It offers Cobroxin for pain medication, XenaCor and XenaTri for cardiovascular health, XenaZyme Plus supports digestion and SunPill for skin protection against ultraviolet rays. The company was founded by Alan P. Xenakis in June 2005 and is headquartered in Tampa, FL. | Health Technology |
| Carlos J. Bonilla & Associates PL |
- Börse
- Insiders
- Carlos Bonilla
- Erfahrung
